Skip to main content
OpenTrials

Clinical trial condition

Severe Acute Respiratory Syndrome

Explore clinical trials studying Severe Acute Respiratory Syndrome. Study availability and eligibility vary by location and protocol.

217 public trials 5 recruiting studies
Refine in advanced search Browse all conditions

Severe Acute Respiratory Syndrome trial results

Completed

COVID-OUT: Early Outpatient Treatment for SARS-CoV-2 Infection (COVID-19)

NCT04510194

Conditions
COVID-19, Coronaviridae Infections, Coronavirus Infections, +12 more
Locations
  • Olive View UCLA Medical Center Sylmar, California, United States
  • University of Colorado Denver; Department of Medicine; Anschutz Health and Wellness Center Aurora, Colorado, United States
  • New West Physicians Golden, Colorado, United States
  • Northwestern University Feinberg School of Medicine Chicago, Illinois, United States
View Trial Details
Completed

Nitric Oxide Gas Inhalation in Severe Acute Respiratory Syndrome in COVID-19

NCT04306393

Conditions
Coronaviridae Infections, Coronavirus, Coronavirus Infections, +8 more
Locations
  • University of Alabama Birmingham, Alabama, United States
  • Louisiana State University Health Shreveport Shreveport, Louisiana, United States
  • Massachusetts General Hospital Boston, Massachusetts, United States
  • Beth Israel Deaconess Medical Center Boston, Massachusetts, United States
View Trial Details
Completed

ACTIV-3b: Therapeutics for Severely Ill Inpatients With COVID-19

NCT04843761

Conditions
COVID-19, Coronaviridae Infections, Coronavirus Infections, +11 more
Locations
  • Banner University Medical Center Tucson (Site 206-004), 1625 N. Campbell Avenue Tucson, Arizona, United States
  • UCSF Fresno (Site 203-005), 155 N. Fresno Street Fresno, California, United States
  • VA Loma Linda Healthcare System (Site 074-017), 11201 Benton Street Loma Linda, California, United States
  • Cedars-Sinai Medical Center (Site 208-002), 8700 Beverly Boulevard Los Angeles, California, United States
View all 40 locations
View Trial Details
Completed

Aviptadil for Severely Ill Inpatients With COVID-19 (An ACTIV-3b/TESICO Treatment Trial)

NCT06729606

Conditions
COVID-19, Coronaviridae Infections, Coronavirus Infections, +11 more
Locations
  • Banner University Medical Center Tucson (Site 206-004), 1625 N. Campbell Avenue Tucson, Arizona, United States
  • UCSF Fresno (Site 203-005), 155 N. Fresno Street Fresno, California, United States
  • VA Loma Linda Healthcare System (Site 074-017), 11201 Benton Street Loma Linda, California, United States
  • Cedars-Sinai Medical Center (Site 208-002), 8700 Beverly Boulevard Los Angeles, California, United States
View all 40 locations
View Trial Details

Related conditions